A Congressional (parlimentary) committee nails MNC pharmas on price gouging - Modi's government is moving towards pharmas to spread their balance sheets to itemise expenditure - Argument that it takes billions to develop a drug over 10-15 year time lines was destroyed during the pandemic
India's Pharma Revolt: How Delhi's Pricing Crackdown Could Upend the Global Drug Industry Parliamentary report exposes thousand-percent markups on decades-old medicines, forcing Modi government to act—and sending tremors through boardrooms from Basel to Boston By Ashok Nilakantan Ayers. Dec 01, 2025 NEW DELHI — In a windowless committee room on Parliament Street, Indian lawmakers have lit a fuse that threatens to detonate the business model of the world's most profitable industry. The numbers are stark, even obscene. A common allergy pill that costs distributors two cents to procure sells on pharmacy shelves for 25 cents—a markup exceeding 1,100 percent. A calcium supplement with a wholesale cost of 20 cents retails at nearly four dollars. A heartburn medication that costs pennies commands more than two dollars at the counter. These figures, buried in a scorching parliamentary committee report released this month, do more than expose pricing abuse in the world'...
